The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...
Many physicians ask themselves the question of whether or not their career accomplishments equated to true fulfillment, David ...
The following is a summary of “MUC5B Promoter Variant and Survival in Rheumatoid Arthritis-Associated Interstitial Lung ...
The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...
The following is a summary of “Need for Institutional Policies for Innovative Therapy: Existing Approaches and Key Elements,” ...
The following is a summary of “Exploring practice staffs’ perspectives regarding professional roles, confidence, and ...
The following is a summary of “Factors and machine learning models for predicting successful discontinuation of continuous ...
The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...
The following is a summary of “Implementation of an Emergency Department Opioid Use Disorder Initiative: Clinical Processes ...
The following is a summary of “Allergic fungal rhinosinusitis linked to other hyper-IgE syndromes through defective TH17 ...
The following is a summary of “Association between perioperative platelet distribution width changes and postoperative acute ...
A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback